Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from AstraZeneca

TOI Health News Morning Briefing| Woman alleges COVID vaccine disabled her, severity of FLiRT COVID variants, measles vaccine ineffective in babies born via C-section, how to spot dehydration in kids, wheat alternatives for diabetics and more

Woman claims AstraZeneca's COVID vaccine permanently disabled her

The Times of India

Vaccine trial patient claims was permanently disabled after taking AstraZeneca's COVID vaccine; here's what happened

Amidst growing concerns around the safety of COVID vaccines developed by AstraZeneca, a new claim has come to the fore. A 42 year old American woman has claimed that she was "permanently disabled" after taking AstraZeneca's COVID vaccine during the clinical trial process. She also claims that her disability was…

The Times of India

Forget Weight-Loss Drugs, Here's the Next Breakthrough Pharma Stock

There is another segment of the pharma industry that is as hot as weight-loss drugs: antibody-drug conjugates, or ADCs. These treatments will, in the near future, replace conventional chemotherapy, thanks to fewer side effects for patients. Even a partial replacement for chemotherapy could make it a $140 billion market -…

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Parents claim death due to Covishield, to file lawsuit against Serum Institute of India

Parents nationwide intend to sue Pune's Serum Institute of India (SII) and government officials responsible for the Covid vaccine rollout. They allege their children's deaths resulted from vaccine side effects. Parents of 8 victims from Kerala, Mumbai, Coimbatore, Hyderabad, Bengaluru, and Kapurthala. This action follows AstraZeneca's acknowledgment in a UK…

The Times of India

AstraZeneca’s Covid vaccine is no more – but its remarkable success must not be forgotten

Although dogged by controversy, the firm’s coronavirus jab saved the lives of millions and helped avert humanitarian crises in nations unable to access costly alternatives

The Guardian - UK

Covishield side effects | Doctors’ group urges Centre to review all COVID vaccines

Doctors express concern over Covishield vaccine safety due to potential blood clot side effects, urging government review and action.

The Hindu

Chemicals in flavoured vapes potentially ‘very toxic when heated’ - Tech & Science Daily

New research suggests chemicals in flavoured vapes could be highly toxic when heated.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Astrazeneca Withdraws Vaxzevria Vaccine Due To Decline In Demand

AstraZeneca withdraws Vaxzevria vaccine due to decreased demand from newer, more effective mRNA vaccines. Strategic shift in global vaccination landscape.

Top News

TOI Health News Morning Briefing | AstraZeneca withdraws COVID vaccine, West Nile fever outbreak, pregnancy guide for summer season, fitness tips and more

AstraZeneca withdraws COVID vaccine worldwide

The Times of India

The Best European Stocks to Buy

European stocks are cheaper than their U.S. counterparts, and there are plenty of high-quality companies to choose from. Here's how you can find them.

Kiplinger

AstraZeneca withdraws Covid vaccine worldwide due to 'surplus'

The pharma giant says the decision was made due to the availability of superior vaccines

Evening Standard

AstraZeneca Withdraws Covid Vaccine As Demand Dives

Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing "commercial reasons" following a slump in demand.

International Business Times

Afternoon Update: US paused weapons shipment to Israel; Hunter Valley bus driver plea deal; and the life expectancy of cats

Senior US official says shipment of bombs was paused last week after review of weapons that might be used in Rafah

The Guardian - AU

AstraZeneca withdraws COVID-19 vaccine worldwide, cites commercial reasons

The pharmaceutical giant AstraZeneca's COVID-19 vaccine is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous side effect, according to a report in the British Newspaper 'The Telegraph'. Read further on Dynamite News:

Dynamite News

Get all your
news in one place.

100's of premium titles.
One news app.

The Times of India

AstraZeneca withdraws COVID vaccine worldwide weeks after admitting rare side effects

British pharmaceutical company AstraZeneca is currently withdrawing its COVID vaccine worldwide, months after it admitted for the first time in court documents that it can cause a rare and dangerous side effect, The Telegraph reported.

The Guardian - AU

AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccines

Pharmaceutical company says newer shots led to decline in demand for AstraZeneca vaccine, which is no longer being manufactured or supplied

The Times of India

The crucial role of accountability in healthcare: Lessons from the Covishield vaccine

In recent times, the field of healthcare has been under scrutiny like never before. The COVID-19 pandemic has not only brought medical challenges but has also highlighted the critical need for accountability in the healthcare field. AstraZeneca's statement regarding rare adverse effects related to blood clotting associated with its COVID-19…

The Hindu

No adverse effects reported from COVID vaccines in India: V. K. Saraswat

No adverse effects have been reported in India with regard to the vaccines used for battling COVID-19, senior scientist and NITI Aayog member V. K. Saraswat said here on Saturday.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is This Dividend Stock a Buy Now?

With a robust portfolio, this top pharma stock is a good mix of growth and income.

Evening Standard

Families 'give up legal action' against Astrazeneca after Covid vaccine blood clot deaths

Twelve families have dropped their cases, according to reports

The Times of India

Covishield under scanner: Is Covaxin safe?

AstraZeneca's statement in court papers has sparked health concerns worldwide, especially in countries like India where COVISHIELD has been given to a large part of the population. The British pharmaceutical giant has admitted that its COVID vaccine can lead to a rare side effect called TTS or Thrombosis with Thrombocytopenia…

The Hindu

In India, all vaccine-related AEFI are routinely monitored and COVID is no exception, says health expert

All ‘Adverse Events Following Immunisation’ (AEFI) after COVID-19 vaccinations continue to be monitored, a senior official said.

Dynamite News

"Safety is primary focus for all our vaccines": Covaxin-developer Bharat Biotech amid reports on AstraZeneca vaccine

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first." Read further on Dynamite News:

The Hindu

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’

Controversy over Covishield safety reaches Supreme Court, petition seeks expert panel to study risk factors and vaccine consequences.

Evening Standard

AstraZeneca's £18.7m boss Soriot bounces back as pharma giant reveals 18% sales growth

Soriot came under fire this month for his £18.7 million pay packet

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Serum Institute of India

11 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.